FY 2025 highlightsIn 2025, Pandora delivered organic revenue growth of 6% (guidance of 7-8%). This comprised of like-for-like (LFL) growth of 2% and network expansion & other of 4%. The EBIT margin ended at 23.9% (guidance of around 24%), down 130bp Y/Y, reflecting the company’s ability to mitigate most of the 300bp external cost headwinds. Strong cash conversion of 65% sees leverage end at 1.3x NIBD/EBITDA. EPS ended at DKK 68, up 5% on a reported basis and up 15% in constant currency.Q4 2025 highlightsQ4 2025 organic growth came in at 4%, comprising of flat LFL and network expansion & other of 4%. Within segments, LFL growth in the Core was flat at 0% whilst Fuel with More declined at -3% LFL. LFL growth in North America slowed to 2%, reflecting the weak consumer sentiment. EMEA was broadly stable at -1% whilst Asia-Pacific...

ANNOUNCEMENT NO. 299 4 February 2026Interim report for the first half of 2025/26         Organic growth despite challenges in the North American market Martin Helbo Behrens, CEO: In the first half of 2025/26, our revenue was up 3% measured in local currencies, while in Danish kroner it was down to DKK 249.0 million, a year-on-year decrease of 1%. Despite this, EBITDA and the EBITDA margin showed a slight increase. Revenue was affected by a sharp slowdown in US demand, as many of our customers in the USA were severely impacted by the historically long government shutdown in the second quarter of 2025/26. Quite exceptionally, our revenue in November was therefore some DKK 20 million lower than last November. In spite of this, we are satisfied with sales of our XcytoMatic instruments, which showed 60% organic growth compared with the year-earlier...

– Net sales decreased 10% year over year, but increased 3% sequentially– Restructuring initiatives to achieve $1.5 million annualized savings substantially complete– Declared a quarterly cash dividend of $0.10 per share LOS ANGELES, Feb. 04, 2026 (GLOBE NEWSWIRE) — Natural Health Trends Corp. (NASDAQ: NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness and “quality of life” products under the NHT Global brand, today announced its financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights  • Revenue of $9.7 million increased 3% compared to $9.5 million in the third quarter of 2025 and declined 10% compared to $10.8 million in the fourth quarter of 2024.  • Operating loss was $635,000 compared to $495,000 and...

MALVERN, Pa., Feb. 04, 2026 (GLOBE NEWSWIRE) — Vishay Intertechnology, Inc., (NYSE: VSH), one of the world’s largest manufacturers of discrete semiconductors and passive electronic components, today announced results for the fiscal fourth quarter and year ended December 31, 2025. Highlights4Q 2025 revenues of $800.9 million Gross margin was 19.6% and included the negative impact of approximately 130 basis points related to Newport 4Q 2025 GAAP EPS of $0.01 4Q 2025 book-to-bill of 1.20 with book-to-bill of 1.27 for semiconductors and 1.13 for passive components Backlog at quarter end was 4.9 months“Fourth quarter financial results capped a year of steadily improving performance. Revenue was 1.3% higher than the third quarter, reflecting growing demand for a broad range of industrial and AI-related power applications,...

Quarterly revenue of $321M – Revenue in line with guidance as Parts and Services continues its year over year and sequential revenue growth but lower than expected truck body production resulted in operational inefficiencies that led to operating income and EPS below expectations. GAAP operating income of $(59.9)M or Non-GAAP adjusted operating income of $(43.8)M and GAAP EPS of $(1.23) or Non-GAAP adjusted EPS of $(0.93). Non-GAAP adjusted operating income and EPS exclude the cost impact of idling two manufacturing facilities. Full year revenue of $1.54B, GAAP EPS of $5.07 per diluted share and Non-GAAP adjusted EPS of $(2.15). Total backlog of $705 million ending Q4; Market environment remains challenging as fleets remain cautious in the near term. Market environment showing early signs of stabilization, setting up for demand...

Fundraised a Record $35 Billion in the Fourth Quarter; $112 Billion for 2025 Quarterly Fee-Related Earnings of $867 Million, Up 28% Year-Over-Year Quarterly Distributable Earnings of $767 Million, Up 18% Year-Over-Year Connor Teskey Appointed CEO of Brookfield Asset Management NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) — Brookfield Asset Management Ltd. (NYSE: BAM, TSX: BAM) (“BAM”), a leading global alternative asset manager headquartered in New York with over $1 trillion of assets under management, today announced record financial results for the quarter ended December 31, 2025; the strongest results since listing. The Board of Directors approved the appointment of Connor Teskey as Chief Executive Officer of BAM. Bruce Flatt will continue in his role as Chair of the Board, in addition to his role as Chief Executive Officer of Brookfield...

Press release                                                                                       Paris, February 4, 2026Record high activity driven by all business linesNet income above €2 billion 2025 KEY FIGURES:Total premium income1 at €52.4 billion, up +20.1%2 Record net inflows3 of +€15.9 billion of which half on the General Account Net income Group share of €2,030 million4, up +7.8%2 excluding the effect of the exceptional corporate income tax Solvency II prudential ratio estimated at ca. 195%“In 2025, as we celebrated the 40th anniversary of Insurance within the Crédit Agricole Group, we have once again demonstrated the capabilities of our model, delivering a remarkably solid performance” said Nicolas Denis, Chief Executive Officer of Crédit Agricole Assurances. “The growth dynamic accelerated, driven by an exceptional...

DYNAMIC ACTIVITY AND STRONG RESULTS IN 2025                   CRÉDIT AGRICOLE S.A. CRÉDIT AGRICOLE GROUP      €m 2025 Var. 2025/2024 2025 Var. 2025/2024    Revenues 28,079 +3.3% 39,558 +3.9%    Expenses -15,628 +4.9% -23,568 +3.7%    Gross Operating Income 12,451 +1.3% 15,990 +4.3%    Cost of risk -1,973 +6.6% -3,452 +8.2%    Net income Group share 7,074 -0.2% 8,754 +1.3%    Cost/income ratio 55.7% +0.9 pp 59.6% -0.1 pp    HIGH FULL-YEAR RESULTSHigh full-year results and profitability (>€7bn for Crédit Agricole S.A., return on tangible equity of 13.5%), driven by record annual revenues that were able to absorb the additional corporate income tax charge (Crédit Agricole Group: €280m, Crédit Agricole S.A €147m) Quarterly results impacted by the effect of the first consolidation of Banco BPM and high-level...

Ad hoc announcement pursuant to Art. 53 LR Full yearNet sales grew +8% (cc1, +8% USD) with core operating income1 up +14% (cc, +12% USD)Sales growth driven by continued strong performance from priority brands including Kisqali (+57% cc), Kesimpta (+36% cc), Pluvicto (+42% cc), Scemblix (+85% cc) and Cosentyx (+8% cc) Core operating income margin1 was 40.1%, +210 basis points (cc)Operating income grew +25% (cc, +21% USD); net income up +19% (cc, +17% USD) Core EPS1 grew +17% (cc, +15% USD) to USD 8.98 Free cash flow1 of USD 17.6 billion (+8% USD) driven by higher net cash flows from operating activitiesFourth quarterNet sales -1% (cc, +1% USD), impacted by US generic erosion and revenue deduction adjustments; core operating income +1% (cc, +1% USD)Priority brands continued their strong momentum including Kisqali (+44% cc),...

Borregaard’s operating revenues increased to NOK 1,833 million (NOK 1,744 million)2 in the 4th quarter of 2025. EBITDA1 was NOK 405 million (NOK 398 million). The result in BioMaterials increased, while BioSolutions and Fine Chemicals had lower results compared with the 4th quarter of 2024. In BioSolutions, high deliveries of biovanillin and sustained growth in sales to agriculture were more than offset by increased costs. For BioMaterials, higher sales prices and lower wood and energy costs, more than compensated for other cost increases. For Fine Chemicals, lower bioethanol sales prices were partly offset by a strong result for fine chemical intermediates. Net currency effects were slightly positive for the Group. In the 4th quarter of 2025, Borregaard has made a total impairment of NOK 245 million of its investments in the bio-based...